| Outcome Measures: |
Primary: Change from Baseline HbA1c at 12 weeks, 0 week, 12 weeks|Changes from Baseline Fasting Blood Glucose at 4 weeks, 8 weeks,12 weeks, 0 week, 4 weeks, 8 weeks,12 weeks|Change from Baseline Postprandial Blood Glucose at 12 weeks, 0 week, 12 weeks|Change from Baseline Low Density Lipoprotein at 12 weeks, 0 week, 12 weeks|Change from Baseline Triglyceride at 12 weeks, 0 week, 12 weeks | Secondary: Changes from Baseline Body Mass Index at 4 weeks, 8 weeks,12 weeks, 0 week, 4 weeks, 8 weeks,12 weeks|Changes from Baseline Waist Circumference at 4 weeks, 8 weeks,12 weeks, 0 week, 4 weeks, 8 weeks,12 weeks|Change from Baseline Total Cholesterol at 12 weeks, 0 week, 12 weeks|Change from Baseline High Density Lipoprotein at 12 weeks, 0 week, 12 weeks|Change from Baseline TCM Symptom Score at 12 weeks, 0 week, 12 weeks | Other: Compositional and Functional Changes from Baseline Gut Microbiota at 12 weeks, 0 week, 12 weeks|Compositional and Functional Changes from Baseline Metabolites in blood and feces at 12 weeks, 0 week, 12 weeks
|
